$ATRC filed an 8-K with results (Item 2.02) at 4:00 PM ET on Tue, Nov 3.
Vote
ATRC
AtriCure, Inc.$58.60CS band Mixed
+$0.53 (0.89%) At close $60.41 · Today
☾After Hours −$1.81 (3.00%) Nov 3, 7:59 PM ET
About ATRC
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Why it moved
Filed an 8-K today reporting results of operations · per SEC
Sources: SEC
From SEC filing · Not investment advice
Why it moved
Filed an 8-K today reporting results of operations · per SEC
From the company’s SEC filing: what was filed, no summary.
Sources: SEC
Written 5:01 PM ET · last check 7:30 PM ET
From SEC filing · Not investment adviceSign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about ATRC?
Board · 0 threads
Open board ›Community opinions, not advice. Posts with a target get a receipt. How receipts work ›